- Trials with a EudraCT protocol (854)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
854 result(s) found for: Medication compliance.
Displaying page 1 of 43.
EudraCT Number: 2005-000374-48 | Sponsor Protocol Number: 104325 | Start Date*: 2005-05-25 |
Sponsor Name:GlaxoSmithKline Pharma A/S | ||
Full Title: A randomized, open label comparative study to determine the proportion of asthma patients on Seretide Diskus 50/250 mcg b.i.d. achieving total control when given medication and compli-ance enhancem... | ||
Medical condition: Asthma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003987-35 | Sponsor Protocol Number: Metamizole001 | Start Date*: 2015-11-10 |
Sponsor Name:JESSA Hospital | ||
Full Title: Metamizole versus NSAID at home after ambulatory surgery: a double-blind randomized controlled trial | ||
Medical condition: Pain after ambulatory surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000307-32 | Sponsor Protocol Number: Repha_1439 | Start Date*: 2020-05-12 | |||||||||||
Sponsor Name:Repha GmbH | |||||||||||||
Full Title: Clinical trial for examination of efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhea-dominant irritable bowel syndrom (IBS-D) | |||||||||||||
Medical condition: Confirmed diagnosis of diarrhea-dominant irritable bowel syndrome (IBS-D) by a specialist physician and/or internal medicine and/or general medicine | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005418-45 | Sponsor Protocol Number: HCQCVDRASLE-1.1 | Start Date*: 2015-05-04 |
Sponsor Name:Christine Bengtsson [...] | ||
Full Title: Improved cardiovascular risk factors and inflammatory markers in Rheumatoid Arthritis and Systemic Lupus Erythematosus? New aspects of Hydroxychloroquine – an interventional study (HCQCVDRASLE) | ||
Medical condition: Rheumatoid Arthritis and Systemic Lupus Erythematosus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004836-31 | Sponsor Protocol Number: Tav01-13 | Start Date*: 2014-04-07 |
Sponsor Name:Montavit Ges.m.b.H. | ||
Full Title: Double-blind, randomised, placebo-controlled study evaluating the efficacy and safety of Tavipec capsules in acute Bronchitis A prsopective, multi-centre, parallel group, interventional clinical ph... | ||
Medical condition: acute bronchitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004473-16 | Sponsor Protocol Number: SL001-2.0 | Start Date*: 2016-07-19 |
Sponsor Name:Masarykův onkologický ústav | ||
Full Title: Prospective study investigating efficacy of lanreotide on decrease of chemotherapy induced diarrhoea (CID) in patiens with colorectal carcinoma. | ||
Medical condition: Chemotherapy induced diarrhoea that is resistant to common treatment including loperamide in patients with colorectal carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002977-23 | Sponsor Protocol Number: Tav02-13 | Start Date*: 2013-12-13 |
Sponsor Name:Montavit Ges.m.b.H. | ||
Full Title: Double-blind, randomised, placebo-controlled study evaluating the efficacy and Safety of Tavipec® capsules in acute Rhinosinusitis A prospective, multi-centre, parallel group, interventional clinic... | ||
Medical condition: Acute Rhinosinusitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001184-28 | Sponsor Protocol Number: PeP-RALP | Start Date*: 2022-10-11 |
Sponsor Name:Oslo University Hospital | ||
Full Title: Perioperative Propranolol in Robotic Assisted Laparoscopic Prostatectomy - A Pilot Study A parallel-group, phase 2, double-blind, 2-arm study to assess the feasibility of conducting a formal large... | ||
Medical condition: Prostate Cancer | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003716-91 | Sponsor Protocol Number: CGB-1108 | Start Date*: 2023-02-21 | |||||||||||
Sponsor Name:Centrum Gastroenterologie Bethanien | |||||||||||||
Full Title: Randomized controlled clinical trial to evaluate the efficacy of alginates in washout of proton pump inhibitor therapy with consideration of compliance and symptom burden in patients with gastroeso... | |||||||||||||
Medical condition: Randomized controlled clinical trial to evaluate the efficacy of alginates in washout of proton pump inhibitor therapy with consideration of compliance and symptom burden in patients with gastroeso... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005265-11 | Sponsor Protocol Number: GWMS0501 | Start Date*: 2006-04-03 |
Sponsor Name:GW Pharma Ltd | ||
Full Title: A double blind, randomised, placebo controlled, parallel group study of Sativex® when added to the existing treatment regimen, in the relief of central neuropathic pain in subjects with multiple sc... | ||
Medical condition: Relief of central neuropathic pain in subjects with multiple sclerosis (MS) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) CZ (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001098-26 | Sponsor Protocol Number: MK-7264-034 | Start Date*: 2018-09-21 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 2a, Proof of Concept, Randomized, Double-blind, Placebo-controlled Clinical Trial, to Evaluate the Efficacy and Safety of MK-7264 in Women with Moderate to Severe Endometriosis-related Pain | |||||||||||||
Medical condition: Moderate to severe Endometriosis-related pain (ERP) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003407-34 | Sponsor Protocol Number: pre-CIN | Start Date*: 2021-06-01 |
Sponsor Name:Oslo University Hospital | ||
Full Title: A randomized clinical three-arm trial comparing inflammation and cystoid macular edema for the medication regimens preoperative and postoperative topical NSAIDs to only postoperative topical NSAIDs... | ||
Medical condition: Cataract surgery, and the medical treatment is anti-inflammatory eye drops to treat (and prevent) intraocular inflammation and development og cystoid macular edema. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004029-87 | Sponsor Protocol Number: KCL/PCT-CT2004-1 | Start Date*: 2005-01-24 |
Sponsor Name:Institute of Psychiatry | ||
Full Title: Pillot randomised controlled trial of antidepressant switching for treatmetn-refractory depression in primary care | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003002-27 | Sponsor Protocol Number: MIT-Es001-C303 | Start Date*: 2020-10-14 | |||||||||||
Sponsor Name:Estetra SRL | |||||||||||||
Full Title: A Multicenter, Open-label, Single-Arm Study to Evaluate the Safety, Compliance and Pharmacokinetics associated with the use of a Combined Oral Contraceptive Containing 15 mg Estetrol monohydrate an... | |||||||||||||
Medical condition: Contraception | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) EE (Completed) LV (Completed) SE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002177-11 | Sponsor Protocol Number: 80-83600-98-20013 | Start Date*: 2015-04-16 |
Sponsor Name:ZonMW GGG | ||
Full Title: Step-down versus step-up analgesics in patients with (sub)acute sciatica in primary care | ||
Medical condition: Patients with (sub)acute sciatica in primary care. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001669-35 | Sponsor Protocol Number: 19139A | Start Date*: 2021-02-01 |
Sponsor Name:H. Lundbeck A/S (Lundbeck) | ||
Full Title: Interventional, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of eptinezumab for the preventive treatment of migraine in patients with a dua... | ||
Medical condition: Preventive treatment of migraine in patients with a dual diagnosis of migraine and Medication Overuse Headache | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004192-37 | Sponsor Protocol Number: CRO1749 | Start Date*: 2012-04-24 | |||||||||||
Sponsor Name:Joint Research Compliance Office, Imperial College | |||||||||||||
Full Title: Hellenic Anglo Research into Morning Or Night antihypertensive drug deliverY trial. | |||||||||||||
Medical condition: Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000619-85 | Sponsor Protocol Number: 2937 | Start Date*: 2005-05-25 |
Sponsor Name:The University of Liverpool [...] | ||
Full Title: The relationship between genetic polymorphisms in the organic cation transporter genes and the pharmacokinetics and pharmacodynamics of metformin | ||
Medical condition: Type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019180-10 | Sponsor Protocol Number: NCTU5248 | Start Date*: 2010-07-29 |
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: Paramedic Initiated Lisinopril For Acute Stroke Treatment(PIL-FAST): A Pilot Randomised Controlled Trial | ||
Medical condition: Stroke and high blood pressure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004008-10 | Sponsor Protocol Number: CICL670AHU02 | Start Date*: 2008-01-08 |
Sponsor Name:Novartis Hungária Kft. | ||
Full Title: Evaluating the efficacy of Exjade® (deferasirox) in transfusion dependent chronic anaemias ( Myelodysplasia Syndrome, Beta-thalassaemia major patients) with chronic iron overload | ||
Medical condition: In- or outpatients with myelodysplasia or beta thalassaemia major, who have chronic iron overload, as a consequence of frequent blood transfusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
